NCT05566717View on ClinicalTrials.gov

An Investigator-Initiated Study to Assess the Association of Diabetic Retinopathy Severity Scale (DRSS) With Level of Decreased Corneal Sensitivity

UnknownOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

September 30, 2022

Study Completion Date

October 31, 2022

Conditions
Diabetic RetinopathyNeurotrophic Keratitis
Trial Locations (1)

78240

RECRUITING

Medical Center Ophthalmology Associates, San Antonio

Sponsors

Collaborators (1)

Oyster Point Pharma, Inc.
All Listed Sponsors
collaborator

Oyster Point Pharma, Inc.

INDUSTRY

lead

Medical Center Ophthalmology Associates

OTHER

NCT05566717 - An Investigator-Initiated Study to Assess the Association of Diabetic Retinopathy Severity Scale (DRSS) With Level of Decreased Corneal Sensitivity | Biotech Hunter | Biotech Hunter